IDENTIFICATION OF IMMUNE-RELATED LNCRNA SIGNATURE TO PREDICT PROGNOSIS AND IMMUNOTHERAPEUTIC EFFICIENCY IN BLADDER CANCER

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer

PurposeIdentify immune-related lncRNA (IRL) signature related to the prognosis and immunotherapeutic efficiency for bladder cancer (BLCA) patients.MethodsA total of 397 samples, which contained RNA-seq and clinical information from The Cancer Genome Atlas (TCGA) database, were used for the following study.Then the Lasso penalized Cox proportional h

read more